Belfast-based health tech company, Neurovalens, has raised £5.1 million in funding led by IQ Capital.
Wharton Asset Management Company, The Angel CoFund (ACF), Techstart Ventures, Clarendon Fund Managers, and the Government’s Future Fund also contributed to the funding round.
The funding will be used for clinical trial research and development in the UK and abroad, as well as hiring additional...
